RESULTS
A total of 130 patients were included in this study. Patients were
divided into 2 groups: survived and deceased. There were 55 patients
(with a mean age of 64.76-14.93 years, 58.18% male, 41.12% female) in
the survived group, while there were 75 patients (with a mean age of
65-15 years, 58.67% male, 41.33% female) in the deceased group. There
was no difference between the groups in terms of age and gender. While
there was no difference between the groups in terms of hypertension,
diabetes mellitus, and cerebrovascular disease, the number of patients
in the deceased group was statistically higher in terms of asthma
(p:0.030) and COPD (p:0.003). The baseline clinical and laboratory
characteristics of the groups are shown in Tables 1 and 2.
The comparison of laboratory characteristics showed that the deceased
group had higher CK-MB (60.88-46.99 vs. 30.55-21.77, p: 0.000), troponin
(106-64.02 vs. 39.87+-14.36, p: 0.000), LDH (554.61-209.22 vs.
365.24+-155.47 p: 0.000), CRP (127-75.32 vs. 87.4-68.24, p: 0.001),
leukocyte (13.01- 4.87 vs. 8.82-4.84, p: 0.000) and D-dimer values
(25.29+-23.09 vs. 1.18+-1.06, p: 0.000).
The electrocardiographic and echocardiographic characteristics are shown
in Table 3. There was no difference between the groups in terms of heart
rate (83.21-19.16 vs. 86.51-17.06, p: 0.290), TPAVR (-0.07+0.26 vs.
0.12+-0.8, p: 0.65), P-R interval (107.51+-7.30 vs. 109+-23.52, p:
0.173), QRS interval (110.52+- 5.71 vs. 112.15+- 9.42, p: 0.333), QT
(393.73+-42.85 vs. 382.22+-27.63, p: 0.11) and QTc intervals
(393.73+-42.85 vs. 382.22+-27.63, p: 0.388), and STAVR/TPAVR ratio
(1.58+-0.79 vs. 1.62+-0.62, p: 0.739). Positive TaVR (28 patients in the
deceased group, 5 patients in the survived group, p:0.000) and STAVR
(0.15+-0.6 vs. 0.19+-0.12, p: 0.002) were statistically significant in
the deceased group. There was no difference between the groups in terms
of left ventricular ejection fraction (p: 0.05). The univariate and
multivariate regression analyses showed that positive TAVR (OR: 5.151,
95% CI: 1.001-26.504, p: 0.0012), lactate dehydrogenase (LDH) (OR:
1.006, 95% CI: 1.001-1.010, p: 0.012) and D-dimer (OR:1.436, 95% CI:
1.115-1.848, p: 0.005) were independent risk factors for mortality.
(Table 4)